Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome
Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome
复制标题
DOI:
10.1542/peds.100.4.593
复制
发表时间:
1997-10-01
期刊:
影响因子:
8
通讯作者:
Davis, JM
中科院分区:
文献类型:
--
作者:
Keszler, M;Modanlou, HD;Davis, JM
Objective. To test the hypothesis that high-frequency jet ventilation (HFJV) will reduce the incidence and/or severity of bronchopulmonary dysplasia (BPD) and acute airleak in premature infants who, despite surfactant administration, require mechanical ventilation for respiratory distress syndrome.Design. Multicenter, randomized, controlled clinical trial of HFJV and conventional ventilation (CV). Patients were to remain on assigned therapy for 14 days or until extubation, whichever came first. Crossover from CV to HFJV was allowed if bilateral pulmonary interstitial emphysema or bronchopleural fistula developed. Patients could cross over to the other ventilatory mode if failure criteria were met. The optimal lung volume strategy was mandated for HFJV by protocol to provide alveolar recruitment and optimize lung volume and ventilation/perfusion perfusion matching, while minimizing pressure amplitude and O-2 requirements. CV management was not controlled by protocol.Setting. Eight tertiary neonatal intensive care units.Patients. Preterm infants with birth weights between 700 and 1500 g and gestational age 0.30 at 2 to 12 hours after surfactant administration, received surfactant by 8 hours of age, were